147 related articles for article (PubMed ID: 11769819)
21. Nortriptyline for treatment-resistant depression.
Nierenberg AA; Papakostas GI; Petersen T; Kelly KE; Iacoviello BM; Worthington JJ; Tedlow J; Alpert JE; Fava M
J Clin Psychiatry; 2003 Jan; 64(1):35-9. PubMed ID: 12590621
[TBL] [Abstract][Full Text] [Related]
22. Age may affect response to antidepressants with serotonergic and noradrenergic actions.
Mulder RT; Watkins WG; Joyce PR; Luty SE
J Affect Disord; 2003 Sep; 76(1-3):143-9. PubMed ID: 12943944
[TBL] [Abstract][Full Text] [Related]
23. Synergistic benefits of serotonin and noradrenaline reuptake inhibition.
Nelson JC
Depress Anxiety; 1998; 7 Suppl 1():5-6. PubMed ID: 9597344
[No Abstract] [Full Text] [Related]
24. Compliance with antidepressant medication in the treatment of major depressive disorder in primary care: a randomized comparison of fluoxetine and a tricyclic antidepressant.
Thompson C; Peveler RC; Stephenson D; McKendrick J
Am J Psychiatry; 2000 Mar; 157(3):338-43. PubMed ID: 10698807
[TBL] [Abstract][Full Text] [Related]
25. Mortality and poststroke depression: a placebo-controlled trial of antidepressants.
Jorge RE; Robinson RG; Arndt S; Starkstein S
Am J Psychiatry; 2003 Oct; 160(10):1823-9. PubMed ID: 14514497
[TBL] [Abstract][Full Text] [Related]
26. Selective serotonin reuptake inhibitors and the tricyclic antidepressant nortriptyline in the treatment of post stroke depression.
Hackett M; Anderson C; House A
Top Stroke Rehabil; 2004; 11(1):viii; author reply ix. PubMed ID: 15000073
[No Abstract] [Full Text] [Related]
27. Nortriptyline for the treatment of depression in progressive supranuclear palsy.
Tamai S; Almeida OP
J Am Geriatr Soc; 1997 Aug; 45(8):1033-4. PubMed ID: 9256865
[No Abstract] [Full Text] [Related]
28. The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression.
Fava M
J Clin Psychiatry; 2003; 64 Suppl 13():26-9. PubMed ID: 14552653
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial.
Taner E; Demir EY; Cosar B
Adv Ther; 2006; 23(6):974-87. PubMed ID: 17276965
[TBL] [Abstract][Full Text] [Related]
30. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
Jones CK; Eastwood BJ; Need AB; Shannon HE
Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
[TBL] [Abstract][Full Text] [Related]
31. The role of norepinephrine in the treatment of depression.
J Clin Psychiatry; 1999 Sep; 60(9):623-31. PubMed ID: 10520985
[No Abstract] [Full Text] [Related]
32. Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline.
Culang-Reinlieb ME; Sneed JR; Keilp JG; Roose SP
Int J Geriatr Psychiatry; 2012 Aug; 27(8):777-84. PubMed ID: 21919060
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular effects of fluoxetine in depressed patients with heart disease.
Roose SP; Glassman AH; Attia E; Woodring S; Giardina EG; Bigger JT
Am J Psychiatry; 1998 May; 155(5):660-5. PubMed ID: 9585718
[TBL] [Abstract][Full Text] [Related]
34. Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile.
Martényi F; Dossenbach M; Mraz K; Metcalfe S
Eur Neuropsychopharmacol; 2001 Jun; 11(3):227-32. PubMed ID: 11418283
[TBL] [Abstract][Full Text] [Related]
35. Noradrenergic versus serotonergic antidepressants: predictors of treatment response.
Schatzberg AF
J Clin Psychiatry; 1998; 59 Suppl 14():15-8. PubMed ID: 9818626
[TBL] [Abstract][Full Text] [Related]
36. Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life.
Bondareff W; Alpert M; Friedhoff AJ; Richter EM; Clary CM; Batzar E
Am J Psychiatry; 2000 May; 157(5):729-36. PubMed ID: 10784465
[TBL] [Abstract][Full Text] [Related]
37. Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients.
Mamo DC; Sweet RA; Mulsant BH; Pollock BG; Miller MD; Stack JA; Begley AE; Reynolds CF
Am J Geriatr Psychiatry; 2000; 8(3):226-31. PubMed ID: 10910421
[TBL] [Abstract][Full Text] [Related]
38. Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients.
Başterzi AD; Yazici K; Aslan E; Delialioğlu N; Taşdelen B; Tot Acar S; Yazici A
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):281-5. PubMed ID: 19110026
[TBL] [Abstract][Full Text] [Related]
39. Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination?
Levitt AJ; Joffe RT; Kamil R; McIntyre R
J Clin Psychiatry; 1999 Sep; 60(9):613-6. PubMed ID: 10520980
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.
Wong ML; Dong C; Flores DL; Ehrhart-Bornstein M; Bornstein S; Arcos-Burgos M; Licinio J
Am J Psychiatry; 2014 Dec; 171(12):1297-309. PubMed ID: 25220861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
